Marylyn Addo

Professor Marylyn Addo serves as Professor and Coordinator of Emerging Infections at University Medical Center Hamburg-Eppendorf (affiliated with University of Hamburg), while also directing the Bridging Topic 'Vaccines'. Her institutional network spans the Hamburg-Lübeck-Borstel-Riems research consortium and multicenter collaborations including Bonn, Köln, and Heidelberg.

Her research centers on emerging viral hemorrhagic fevers (Ebola, MERS, Lassa, Crimean-Congo) with integrated focus on immunology, vaccine development, anti-infective testing, and outbreak management. Concurrently, she leads the mEX-TB study to identify biomarkers for extrapulmonary tuberculosis diagnosis and treatment optimization through prospective multicenter clinical-biosample analysis.

Professor Addo's publication record demonstrates active translational research, including 2025 environmental virology work on Hepatitis E in marine ecosystems. Her projects maintain strong clinical relevance through direct pathways to improved patient management protocols and outbreak response frameworks.

She directs active research programs with substantial multicenter funding, evidenced by ongoing leadership in the mEX-TB consortium and emerging infections network. These initiatives facilitate resource sharing across German medical centers and research institutes for high-impact infectious disease studies.

Professor Addo's Emerging Infections group operates within University Medical Center Hamburg-Eppendorf's translational research infrastructure, leveraging the Hamburg-Lübeck-Borstel-Riems network for comprehensive pathogen surveillance, immunology studies, and therapeutic development against high-consequence emerging pathogens.